Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synsam ABCHIX:SYNSAS 85 PS Ratio is 1.20 as of Aug. 04, 2026, which is 2% below its 10-year median of 1.22. GuruFocus rates CHIX:SYNSAS with a GF Score™ of 85/100 and a GF Value™ of kr64.34. The stock has 1 warning sign investors should review. Among 804 Medical Devices & Instruments companies, Synsam AB ranks better than 77.24% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Synsam AB's share price is kr59.80.
Synsam AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr49.63. Hence, Synsam AB's PS Ratio for today is 1.20.
Good Sign:
Synsam AB stock PS Ratio (=1.15) is close to 1-year low of 1.05.
The historical rank and industry rank for Synsam AB's PS Ratio or its related term are showing as below:
CHIX:SYNSAs'
s PS Ratio Range Over the Past 10 Years
Min: 0.85 Med: 1.22 Max: 3.28
Current: 1.15
During the past 8 years, Synsam AB's highest PS Ratio was 3.28. The lowest was 0.85. And the median was 1.22.
CHIX:SYNSAs's PS Ratio is ranked better than 77.24% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.935
vs CHIX:SYNSAs: 1.15
Synsam AB's Revenue per Sharefor the
three
months ended in Mar. 2026 was kr12.46.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr49.63.
During the past 12 months, the average Revenue per Share Growth Rate of Synsam AB was 10.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 13.50% per year.
During the past 8 years, Synsam AB's highest 3-Year average Revenue per Share Growth Rate was 16.00% per year. The lowest was 11.50% per year. And the median was 11.90% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Synsam AB PS Ratio Related Terms
Synsam AB PS Ratio Historical Data
* Premium members only.
The historical data trend for Synsam AB's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SYNSAS vs ISRG, BDX, MDLN: PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, Synsam AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synsam AB PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synsam AB's PS Ratio distribution charts can be found below:
* The bar in red indicates where Synsam AB's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Synsam AB's Share Price of today is kr59.80. Synsam AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr49.63.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Synsam AB (CHIX:SYNSAS) has a PS Ratio of 1.20 as of Aug. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Synsam AB and its competitors. This is near median its historical median of 1.22. Over the past decade, Synsam AB's PS Ratio has ranged from 0.85 to 3.28. According to the industry distribution chart, Synsam AB ranks #183 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 22.8%.
Is Synsam AB's PS Ratio too high?
Synsam AB's current PS Ratio of 1.20 is near median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 3.28. The Medical Devices & Instruments industry median PS Ratio is 2.94. Synsam AB's value of 1.20 is 59.1% below this industry median. Based on the distribution chart, Synsam AB ranks #183 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Synsam AB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Synsam AB's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Synsam AB ranks #183 out of 804 companies for PS Ratio. This places Synsam AB in the top 23% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.94. Synsam AB's value of 1.20 is 59.1% below this benchmark. Historically, Synsam AB's own PS Ratio has ranged from 0.85 to 3.28 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 2.94, Synsam AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synsam AB's current PS Ratio of 1.20 is 59.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Synsam AB and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synsam AB's current PS Ratio is 1.20, which is near median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synsam AB stock overvalued right now?
Synsam AB (CHIX:SYNSAS) has a current PS Ratio of 1.20. The stock's GF Value™ is kr64.34, compared to a current price of kr59.80 — trading 7.1% below its estimated fair value. The current PS Ratio is 1.20, which is near median its 10-year median of 1.22 and 59.1% below the Medical Devices & Instruments industry median of 2.94. Synsam AB's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Synsam AB (CHIX:SYNSAS), the current PS Ratio is 1.20 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synsam AB (CHIX:SYNSAS) Overvalued in 2026?
Based on GuruFocus' analysis, Synsam AB stock appears to be undervalued.
The current stock price of kr59.80 is trading 7.1% below its estimated GF Value™ of kr64.34.
Key valuation signals for CHIX:SYNSAS:
PS Ratio: 1.20 (near median its 10-year median of 1.22)
GF Value™: kr64.34 vs. price of kr59.80 (7.1% below fair value)
Industry Position: 59.1% below the Medical Devices & Instruments median (#183 of 804)
No single metric tells the full story. See the CHIX:SYNSAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synsam AB is a lifestyle company in optics and eye health in the Nordic region. The company offers various products and services in physical and digital stores, such as eye examinations, spectacles, sunglasses, sports spectacles, contact lenses, and accessories in optical retail, as well as spectacles subscriptions and related services under the name Synsam Lifestyle. Its stores are operated under the Synsam brand in Sweden, Norway, and Finland, and under the Profil Optik brand in Denmark and Iceland. The company comprises four segments: Sweden, which generates key revenue, Denmark, Norway, and Finland.
85GF Score
Get the complete analysis for CHIX:SYNSAS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SYNSAS has been successfully added to your 
